← Leaderboards
Charles August Schurman
University Of California, San Francisco
$101,537
Attributed
$101,537
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $37.7K · FY2019–21$50K$37.5K$25K$12.5K$0
'19
'20
'21
Funding mix
By agency
NIH$101,537 · 1
By mechanism
F31$101,537 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Galateia J Kazakia$8,810,670
- Tamara N Alliston$9,755,404
- Julio Carballido-Gamio$2,678,369
- Xiaojuan Li$11,947,001
- Neera Gupta$5,839,237
Others in their field
Other Emerging Leaders on “Advanced Glycosylation End Products”
- Raja G Khalifah · Praetego, Inc.$5,752,037
- Colleen Bauza · Jaeb Center For Health Research, Inc.$4,053,339
- Viral N Shah · University Of Colorado Denver$2,628,424
- Guowei Su · Glycan Therapeutics Corporation$2,405,945
- Malia Michelle Edwards · Johns Hopkins University$2,372,735
- Maria Luiza A Caramori · University Of Minnesota$2,306,563
Research focus
Advanced Glycosylation End ProductsAffectAgedAge EffectAge RelatedAge-Related Bone LossAgingArchitectureBaseBehaviorBiochemicalBiocompatible MaterialsBiologicalBoneBone AgingBone CellBone FragilityBone HealthBone LossBone MassBone MatrixBone QualityBone Remodeling3-Dimensional
Grant awards (3)
Age-related Control of Bone Quality by Osteocyte TGF-beta Signaling$27,009
F31 · FY2021 · AG · contact PI
Age-related Control of Bone Quality by Osteocyte TGF-beta Signaling$37,749
F31 · FY2020 · AG · contact PI
Age-related Control of Bone Quality by Osteocyte TGF-beta Signaling$36,779
F31 · FY2019 · AG · contact PI